Xia Leilei, Wang Xianjin, Xu Tianyuan, Zhang Xiaohua, Zhu Zhaowei, Qin Liang, Zhang Xiang, Fang Chen, Zhang Minguang, Zhong Shan, Shen Zhoujun
Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P. R. China.
PLoS One. 2015 Mar 31;10(3):e0121032. doi: 10.1371/journal.pone.0121032. eCollection 2015.
To critically review the currently available evidence of studies comparing robot-assisted radical cystectomy (RARC) with open radical cystectomy (ORC).
A comprehensive review of the literature from Pubmed, Web of Science and Scopus was performed in April 2014. All relevant studies comparing RARC with ORC were included for further screening. A pooled meta-analysis of all comparative studies was performed and publication bias was assessed by a funnel plot.
Nineteen studies were included for the analysis, including a total of 1779 patients (787 patients in the RARC group and 992 patients in the ORC group). Although RARC was associated with longer operative time (p <0.0001), patients in this group might benefit from significantly lower overall perioperative complication rates within 30 days and 90 days (p = 0.005 and 0.0002, respectively), more lymph node yields (p = 0.009), less estimated blood loss (p <0.00001), lower need for perioperative and intraoperative transfusions (p <0.0001 and <0.0001, respectively), and shorter postoperative length of stay (p = 0.0002). There was no difference between two groups regarding positive surgical margin rates (p = 0.19).
RARC appears to be an efficient alternative to ORC with advantages of less perioperative complications, more lymph node yields, less estimated blood loss, lower need for transfusions, and shorter postoperative length of stay. Further studies should be performed to compare the long-term oncologic outcomes between RARC and ORC.
严格审查目前比较机器人辅助根治性膀胱切除术(RARC)与开放性根治性膀胱切除术(ORC)的现有研究证据。
2014年4月对来自PubMed、科学网和Scopus的文献进行了全面综述。纳入所有比较RARC与ORC的相关研究以进行进一步筛选。对所有比较研究进行汇总的荟萃分析,并通过漏斗图评估发表偏倚。
纳入19项研究进行分析,共1779例患者(RARC组787例患者,ORC组992例患者)。虽然RARC与手术时间较长相关(p<0.0001),但该组患者可能受益于30天和90天内总体围手术期并发症发生率显著降低(分别为p = 0.005和0.0002)、更多的淋巴结获取量(p = 0.009)、更少的估计失血量(p<0.00001)、围手术期和术中输血需求较低(分别为p<0.0001和<0.0001)以及术后住院时间较短(p = 0.0002)。两组在手术切缘阳性率方面无差异(p = 0.19)。
RARC似乎是ORC的一种有效替代方法,具有围手术期并发症较少、淋巴结获取量更多、估计失血量较少、输血需求较低以及术后住院时间较短的优点。应进行进一步研究以比较RARC与ORC之间的长期肿瘤学结局。